AR058959A1 - Metodos para modular receptores de la superficie celular para prevenir o reducir la inmflamacion - Google Patents

Metodos para modular receptores de la superficie celular para prevenir o reducir la inmflamacion

Info

Publication number
AR058959A1
AR058959A1 ARP070100086A ARP070100086A AR058959A1 AR 058959 A1 AR058959 A1 AR 058959A1 AR P070100086 A ARP070100086 A AR P070100086A AR P070100086 A ARP070100086 A AR P070100086A AR 058959 A1 AR058959 A1 AR 058959A1
Authority
AR
Argentina
Prior art keywords
species
bacterium
methods
deleterious
immflamation
Prior art date
Application number
ARP070100086A
Other languages
English (en)
Inventor
Sreenivasan Prem
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38017086&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR058959(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of AR058959A1 publication Critical patent/AR058959A1/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56955—Bacteria involved in periodontal diseases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G01N2021/6439—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/18—Dental and oral disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)

Abstract

Un método para distinguir especies de bacterias orales a fin de determinar si una especie es oralmente deletérea. Dicho método incluye poner en contacto al menos una bacteria o una porcion de una bacteria de una especie de bacteria oral con una célula gingival; y detectar la presencia de un compuesto indicador. La ausencia sustancial de un material indicador significa que la especie de bacteria no es deletérea. También están incluidos en el alcance de la presente métodos para determinar el efecto antiinflamatorio de un agente. Dichos métodos incluyen poner en contacto la célula con el agente en presencia de una bacteria deletérea o una porcion de dicha bacteria y detectar la presencia de un compuesto indicador. La ausencia sustancial de un material indicador significa que el agente es antiinflamatorio. Reivindicacion 1: Un método para distinguir especies de bacterias orales, caracterizado porque comprende: (a) poner en contacto al menos una bacteria o porcion de una bacteria de una especie de bacteria oral con una célula gingival; y (b) detectar la presencia de un compuesto indicador donde la ausencia sustancial de un material indicador significa que la especie de bacteria no es deletérea.
ARP070100086A 2006-01-10 2007-01-09 Metodos para modular receptores de la superficie celular para prevenir o reducir la inmflamacion AR058959A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75775106P 2006-01-10 2006-01-10

Publications (1)

Publication Number Publication Date
AR058959A1 true AR058959A1 (es) 2008-03-05

Family

ID=38017086

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070100086A AR058959A1 (es) 2006-01-10 2007-01-09 Metodos para modular receptores de la superficie celular para prevenir o reducir la inmflamacion

Country Status (18)

Country Link
US (1) US9157914B2 (es)
EP (2) EP2177621B1 (es)
JP (2) JP2009523029A (es)
CN (1) CN101371141A (es)
AR (1) AR058959A1 (es)
AU (1) AU2007204730B2 (es)
BR (1) BRPI0706505A2 (es)
CA (2) CA2849559A1 (es)
DK (2) DK2177621T3 (es)
ES (2) ES2421595T3 (es)
HK (2) HK1121235A1 (es)
MY (1) MY151118A (es)
PH (1) PH12014501163A1 (es)
PL (2) PL2177621T3 (es)
RU (1) RU2431845C2 (es)
TW (2) TW200801514A (es)
WO (1) WO2007082181A2 (es)
ZA (1) ZA200805730B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009523029A (ja) * 2006-01-10 2009-06-18 コルゲート・パーモリブ・カンパニー 炎症の予防または軽減のために、細胞表面受容体を調節する方法
WO2010120275A2 (en) 2009-04-01 2010-10-21 Colgate-Palmolive Company Menthol-derivative compounds and use thereof as oral and systemic active agents
TWI405565B (zh) 2009-04-01 2013-08-21 Colgate Palmolive Co 口腔用組成物之抗－骨質流失及抗－牙周附連喪失之功效
AR076041A1 (es) * 2009-04-01 2011-05-11 Colgate Palmolive Co Biomarcadores de proteina para el diagnostico de enfermedades de tejido blando y como objetivos terapeuticos para intervenciones de cuidado oral
WO2010114533A1 (en) 2009-04-01 2010-10-07 Colgate-Palmolive Company Anti-biofilm carbonate compounds for use in oral care compositions
EP3292215A1 (en) 2015-05-06 2018-03-14 The Procter and Gamble Company Detoxification of microbial virulence factors in oral cavity
US9964472B2 (en) 2016-06-29 2018-05-08 The Procter & Gamble Company Methods for sampling gingival metabolites
CA3177046A1 (en) * 2020-04-02 2021-10-07 Colgate-Palmolive Company Compositions for and methods of neutralizing lipopolysaccharide toxicity and methods of identifying the same

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538230A (en) * 1966-12-05 1970-11-03 Lever Brothers Ltd Oral compositions containing silica xerogels as cleaning and polishing agents
US4358437A (en) * 1978-11-29 1982-11-09 Beecham Group Limited Compositions
US5288480A (en) * 1987-01-30 1994-02-22 Colgate-Palmolive Co. Antiplaque antibacterial oral composition
GB9117140D0 (en) 1991-08-08 1991-09-25 Unilever Plc Treatment of periodontitis
DE4226043A1 (de) * 1992-08-06 1994-02-10 Haarmann & Reimer Gmbh Mittel mit physiologischem Kühleffekt und für diese Mittel geeignete wirksame Verbindungen
EP0728017A1 (en) * 1993-11-10 1996-08-28 Bristol-Myers Squibb Company Treatment of bacterially-induced inflammatory diseases
US5578295A (en) * 1995-04-28 1996-11-26 The Procter & Gamble Company Oral care compositions comprising certain substituted diphenyl ethers
AUPN627595A0 (en) 1995-10-30 1995-11-23 University Of Melbourne, The Diagnostics and treatments of periodontal disease
JP2000512285A (ja) 1996-06-12 2000-09-19 ヘンケル・コマンディットゲゼルシャフト・アウフ・アクチエン 化粧品および／または薬剤製剤
EP0863402B1 (en) 1997-03-03 2005-09-14 Amersham Biosciences UK Limited In-situ cell extraction and assay method
JP2000128900A (ja) 1998-10-26 2000-05-09 Japan Science & Technology Corp 新規トル様（Ｔｏｌｌ−ｌｉｋｅ）レセプター及びその遺伝子
FR2794457B1 (fr) 1999-06-01 2001-08-10 Oreal Derives carbonates de retinol, procede de preparation et utilisations
US6696261B2 (en) 1999-12-03 2004-02-24 Baxter International Inc. Pyrogenicity test for use with automated immunoassay systems
GB0001704D0 (en) * 2000-01-25 2000-03-15 Glaxo Group Ltd Protein
US7329489B2 (en) * 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
EP2330219A3 (en) * 2000-04-14 2011-11-23 Metabolon, Inc. Method for drug discovery, disease treatment and diagnosis using metabolomics
US6500409B1 (en) 2000-05-10 2002-12-31 Colgate Palmolive Company Synergistic antiplaque/antigingivitis oral composition
DE10059584A1 (de) 2000-11-30 2002-06-06 Beiersdorf Ag Kosmetische oder dermatologische getränkte Tücher
PL366250A1 (en) 2000-12-29 2005-01-24 Reddy Us Therapeutics, Inc. Detection of compounds that modulate inflammatory responses
WO2003006026A1 (en) 2001-07-09 2003-01-23 Combinatorx, Incorporated Combinations for the treatment of inflammatory disorders
US6893828B2 (en) 2001-09-06 2005-05-17 Decode Genetics Ehf. Methods for producing ex vivo models for inflammatory disease and uses thereof
AU2003225088A1 (en) 2002-04-19 2003-11-03 Vertex Pharmaceuticals Incorporated Regulation of tnf-alpha
US7005225B2 (en) * 2002-11-12 2006-02-28 Samsung Electronics Company Organosol including amphipathic copolymeric binder having crystalline material, and use of the organosol to make dry tones for electrographic applications
TW200509958A (en) * 2003-02-14 2005-03-16 Combinatorx Inc Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
GB2401865A (en) 2003-05-22 2004-11-24 Givaudan Sa Antibacterial and antifungal glycerol monocarbonates
US7202234B2 (en) * 2003-10-24 2007-04-10 Eisai Co., Ltd. Compounds and methods for treating Toll-like receptor 2-related diseases and conditions
JP2007519894A (ja) * 2003-12-03 2007-07-19 ホワイトヘッド インスティテュート フォー バイオメディカル リサーチ 標的としてのカドヘリンの使用
JP2005304365A (ja) 2004-04-20 2005-11-04 Japan Science & Technology Agency Ｔｌｒリガンド及びｉｌ−１応答障害性モデル動物
FI20040572A0 (fi) 2004-04-23 2004-04-23 Ctt Cancer Targeting Tech Oy Matriisi-metalloproteinaasin aktiviteetin inhibiittorit
US20060141421A1 (en) * 2004-12-28 2006-06-29 Kimberly-Clark Worldwide, Inc. System and method for detecting substances related to oral health
WO2006074450A2 (en) * 2005-01-07 2006-07-13 President And Fellows Of Harvard College Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases
JP2009523029A (ja) * 2006-01-10 2009-06-18 コルゲート・パーモリブ・カンパニー 炎症の予防または軽減のために、細胞表面受容体を調節する方法
US20080161394A1 (en) 2006-11-23 2008-07-03 Jean-Yves Fouron Cosmetic composition comprising at least one volatile carbonic acid ester
WO2008093072A2 (en) 2007-01-29 2008-08-07 Paul Webb Topical composition against contact dermatitis due to water
WO2009048841A1 (en) 2007-10-09 2009-04-16 Humco Holding Group, Inc. Antifungal treatment of nails

Also Published As

Publication number Publication date
MY151118A (en) 2014-04-15
CA2635605A1 (en) 2007-07-19
JP2015051000A (ja) 2015-03-19
TW201415028A (zh) 2014-04-16
CA2849559A1 (en) 2007-07-19
CN101371141A (zh) 2009-02-18
EP2177621A2 (en) 2010-04-21
AU2007204730B2 (en) 2011-11-17
AU2007204730A1 (en) 2007-07-19
ES2431291T3 (es) 2013-11-25
PL2177621T3 (pl) 2014-03-31
JP2009523029A (ja) 2009-06-18
RU2431845C2 (ru) 2011-10-20
DK1971865T3 (da) 2013-07-08
ZA200805730B (en) 2014-12-23
HK1141838A1 (en) 2010-11-19
BRPI0706505A2 (pt) 2011-03-29
EP2177621A3 (en) 2010-09-08
PH12014501163A1 (en) 2015-05-18
WO2007082181A3 (en) 2007-09-27
HK1121235A1 (en) 2009-04-17
CA2635605C (en) 2014-07-08
RU2008132839A (ru) 2010-02-20
PL1971865T3 (pl) 2014-02-28
EP2177621B1 (en) 2013-10-09
US20070160544A1 (en) 2007-07-12
DK2177621T3 (da) 2013-10-28
US9157914B2 (en) 2015-10-13
EP1971865A2 (en) 2008-09-24
EP1971865B1 (en) 2013-04-17
WO2007082181A2 (en) 2007-07-19
ES2421595T3 (es) 2013-09-04
TW200801514A (en) 2008-01-01

Similar Documents

Publication Publication Date Title
AR058959A1 (es) Metodos para modular receptores de la superficie celular para prevenir o reducir la inmflamacion
CL2009002114A1 (es) Un método para detectar al menos un olor en una muestra de gas que comprende: reducir, al menos parcialmente, una cantidad de agua en la muestra de gas; y detectar la presencia o ausencia de olor en la muestra; se describe además un aparato para detectar y/o medir olores en una muestra de gas.
ATE539165T1 (de) Verfahren zum nachweis von beta-lactamase
CY1120961T1 (el) Δοσολογικες μορφες απο του στοματος που περιλαμβανουν αντιαιμοπεταλιακο παραγοντα και αναστολεα οξεος
EP1383914A4 (en) IMPROVED METHOD FOR DETECTING ATP
TW200636245A (en) Colorimetric sensors constructed of diacetylene materials
TW200728704A (en) Apparatus and method for measuring real-time corrosion
BR112015004881A2 (pt) método para diagnosticar o estado da doença periodontal e kit para diagnosticar o estado da doença periodontal
WO2005041893A3 (en) Detection of acute myocardial infarction biomarkers
MA30922B1 (fr) Anticorps d'agonistes de trkb et leurs utilisations
WO2006020579A3 (en) Method for rapid identification of microorganisms
TW200636075A (en) Detection of nucleic acid variation by cleavage-amplification method
MX2009013645A (es) Deteccion de coproantigeno de ascaride.
DE60228557D1 (de) Candida-nachweis
SE0400191D0 (sv) A test kit for detecting periodontal disease
HK1129240A1 (en) Dna recombination junction detection
TW200636473A (en) Configuration device and method for current output at USB port
GB2445488A (en) System for spore detection
DE60124975D1 (de) Automatischer apparat zum messen von wassertoxizität
MX2009010751A (es) Composiciones y metodos de deteccion.
TW200745551A (en) Device and methods for detecting and quantifying one or more target agents
AR076113A1 (es) Metodo o sistema que usa biomarcadores para el seguimiento de un tratamiento
ATE528389T1 (de) Hemmtestverfahren und -vorrichtung zum nachweis von antibiotika
WO2004099784A3 (en) Method for determining a tissue degradation process by detection of fibromodulin neoepitopes
TW200724307A (en) Wear monitoring system for a conveyor and method thereof

Legal Events

Date Code Title Description
FB Suspension of granting procedure